UK guidelines for the management of bone sarcomas
Craig Gerrand, Fernanda Amary, Hanny Anwar, Bernadette Brennan, Palma Dileo, Maninder Kalkat, Martin G. McCabe, Anna Louise McCullough, Michael Parry, Anish Patel, Beatrice Seddon, Jenny Sherriff, Roberto Tirabosco, Sandra J. Strauss
Abstract
This document is an update of the British Sarcoma Group guidelines (2016) and provides a reference standard for the clinical care of UK patients with primary malignant bone tumours (PMBT) and giant cell tumours (GCTB) of bone. The guidelines recommend treatments that are effective and should be available in the UK, and support decisions about management and service delivery. The document represents a consensus amongst British Sarcoma Group members in 2024. Key recommendations are that bone pain, or a palpable mass should always lead to further investigation and that patients with clinical or radiological findings suggestive of a primary bone tumour at any anatomic site should be referred to a specialist centre and managed by an accredited bone sarcoma multidisciplinary team. Treatment recommendations are provided for the major tumour types and for localised, metastatic and recurrent disease. Follow-up schedules are suggested.